Summary

この調査レポートは世界の分子診断薬（MDx）市場を調査し、タイプ別、用途別、エンドユーザー別、地域別に2022年から2032年までの予測結果を掲載しています。また関連企業情報を提供しています。

主な掲載内容（目次より抜粋）

1. レポート概要
2. エグゼクティブサマリー
3. プレミアムインサイト
4. 市場概要
5. 世界の分子診断薬市場分析：タイプ別
6. 世界の分子診断薬市場分析：用途別
7. 世界の分子診断薬市場分析：エンドユーザー別
8. 世界の分子診断薬市場分析：地域別
9. 北米の分子診断薬市場分析
10. 欧州の分子診断薬市場分析
11. アジア太平洋地域の分子診断薬市場分析
12. ラテンアメリカの分子診断薬市場分析
13. 中東・アフリカの分子診断薬市場分析
14. 競争状況
15. 主要企業のプロフィール

Report Details

The Molecular Diagnostics (MDx) Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Need for Point of Care Diagnostics is One of The Key Factor Driving the Market Growth
Portable molecular diagnostics include assays and kits used to detect and diagnose diseases in human samples such as throat swabs, blood, serum, and stool. Molecular diagnostics are moving away from centralised laboratories and toward point-of-care molecular testing.

Point-of-care testing, also known as POC testing, is a type of medical testing done at or near the point of care. POC indicates the site of the patient. Sending all samples and specimens away to be processed at medical laboratories means waiting a long time for results. POC tests can greatly improve the management of infectious diseases, especially in developing countries where access to timely medical care faces numerous challenges and the healthcare infrastructure is still old.

The rising prevalence of various diseases has accelerated the development of point-of-care testing methods, fueling the growth of the molecular diagnosis market. According to UNAIDS Data of 2020, approximately 20.6 million people in East and Southern Africa were living with HIV in 2018. In the Middle East and North Africa in 2019, 20,000 new HIV cases were reported.

In 2019, an estimated 5.8 million people in Asia Pacific were infected with HIV, with India and China leading the way. According to UNAIDS, approximately 2.1 million people in India were HIV-positive in 2019. The high prevalence of HIV is expected to increase demand for point-of-care diagnostics, hastening the treatment of HIV infection.

Rising number of vaccinations globally along with higher prices of molecular tests
The COVID-19 outbreak sparked a race in the diagnostics industry to create novel and rapid coronavirus detection kits. Companies in the infectious diseases segment saw an increase in revenue as a result of the pandemic. For example, Thermo Fisher Scientific reported a 59 percent increase in revenue in April 2021, owing to a 150 percent increase in the diagnostics division. However, as global vaccination rates increase, demand for COVID-19 diagnostics is expected to decrease during the forecast period.

Molecular diagnostics provides precise and effective results and has critical applications in disease diagnosis. However, one of the major impediments to this market is the high cost of molecular tests.

What Questions Should You Ask before Buying a Market Research Report?
• How is the molecular diagnostics market evolving?
• What is driving and restraining the molecular diagnostics market?
• How will each molecular diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each molecular diagnostics submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading molecular diagnostics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the molecular diagnostics projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032? What are the implications of molecular diagnostics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the molecular diagnostics market?
• Where is the molecular diagnostics market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the molecular diagnostics market today, and over the next 10 years:
• Our 236-page report provides 106 tables and 173 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the molecular diagnostics market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

The report delivers exclusive COVID-19 variations and economic data specific to your market.

Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising molecular diagnostics prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Type Outlook
• Testing service provider
• Diagnostic Manufacturers
• OEM
• Software Providers

Application
• Infectious Disease Diagnostics
– COVID-19
– Hepatitis
– HIV
– CT/NG
– HAI
– HPV
– Tuberculosis
– Influenza
– Others
• Oncology Testing
• Genetic Tests
• Others

End User
• Diagnostic Laboratories
• Hospitals and Clinics
• Other End Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America
• U.S.
• Canada
• Mexico

Europe
• Germany
• Spain
• United Kingdom
• France
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

LAMEA
• Brazil
• Turkey
• Saudi Arabia
• South Africa
• UAE
• Rest of Latin America

The report also includes profiles and for some of the leading companies in the Molecular Diagnostics Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Abbott Laboratories Inc
• F. Hoffmann-La Roche Ltd.
• Hologic Inc.
• Qiagen N.V.
• Becton, Dickinson and Company
• Cepheid
• Siemens Medical Solutions Inc.
• Danaher Corp.
• Agilent Technologies Inc.
• Exact Sciences Corp
• Abacus Diagnostica Oy [Uniogen] • PerkinElmer, Inc.
• bioMérieux SA
• Thermo Fisher Scientific

Overall world revenue for Molecular Diagnostics Market, 2022 to 2032 in terms of value the market will surpass US$23,498.2 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Molecular Diagnostics Market, 2022 to 2032 report help you?
In summary, our 230+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Molecular Diagnostics Market, 2022 to 2032 Market, with forecasts for process, upstream, downstream, type and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2032 for four regional and 20 key national markets – See forecasts for the Molecular Diagnostics Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 20 of the major companies involved in the Molecular Diagnostics Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Molecular Diagnostics Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

Table of Contents

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Molecular Diagnostics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by the Analytical Report Include:
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Premium Insights
3.1 Type Snapshot: Global Molecular Diagnostics Market
3.2 Application Segment: Market Attractiveness Index
3.3 End User Segment: Market Attractiveness Index
3.4 Regional Segment: Market Attractiveness Index

4 Market Overview
4.1 Key Findings
4.2 Market Dynamics
4.2.1 Market Driving Factors
4.2.2 Market Restraining Factors
4.2.3 Market Opportunities
4.3 Porter’s Five Forces Analysis
4.3.1 Supplier Power
4.3.2 Buyer Power
4.3.3 Competitive Rivalry
4.3.4 Threat from Substitutes
4.3.5 Threat of New Entrants
4.4 PESTEL Analysis

5 Global Molecular Diagnostics Market Analysis by Type
5.1 Key Findings
5.2 Type Segment Growth Prospects
5.3 Global Molecular Diagnostics Market Share by Type, 2022 & 2032
5.4 Testing Service Provider
5.4.1 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ Mn)
5.4.2 Testing Service Provider Market Share by Region, 2022-2032 (%)
5.5 Diagnostic Kit Manufacturers
5.5.1 Diagnostic Kit Manufacturers Market Forecast by Region, 2022-2032 (US$ Mn)
5.5.2 Diagnostic Kit Manufacturers Market Share by Region, 2022-2032 (%)
5.6 OEM
5.6.1 OEM Market Forecast by Region, 2022-2032 (US$ Mn)
5.6.2 OEM Market Share by Region, 2022-2032 (%)
5.7 Software Providers
5.7.1 Software Providers Market Forecast by Region, 2022-2032 (US$ Mn)
5.7.2 Software Providers Market Share by Region, 2022-2032 (%)

6 Global Molecular Diagnostics Market Analysis by Application
6.1 Key Findings
6.2 Application Segment Growth Prospects
6.3 Global Molecular Diagnostics Market Share by Application, 2022 & 2032
6.4 Infectious Disease Testing
6.4.1 Infectious Disease Testing Market Forecast by Region, 2022-2032 (US$ Mn)
6.4.2 Infectious Disease Testing Market Share by Region, 2022-2032 (%)
6.4.3 HIV Market Share by Region, 2022-2032 (%)
6.4.4 CT/NG Market Share by Region, 2022-2032 (%)
6.4.5 HAI Market Share by Region, 2022-2032 (%)
6.4.6 Influenza Market Share by Region, 2022-2032 (%)
6.5 Oncology Testing
6.5.1 Oncology Testing Market Forecast by Region, 2022-2032 (US$ Mn)
6.5.2 Oncology Testing Market Share by Region, 2022-2032 (%)
6.6 Genetic Testing
6.6.1 Genetic Testing Market Forecast by Region, 2022-2032 (US$ Mn)
6.6.2 Genetic Testing Market Share by Region, 2022-2032 (%)
6.7 Others
6.7.1 Others Market Forecast by Region, 2022-2032 (US$ Mn)
6.7.2 Others Market Share by Region, 2022-2032 (%)

7 Global Molecular Diagnostics Market Analysis by End User
7.1.1 Key Findings
7.1.2 End User Segment Growth Prospects
7.2 Global Molecular Diagnostics Market Size Estimation and Forecast by End User
7.3 Diagnostic Laboratories
7.3.1 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ Mn)
7.3.2 Diagnostic Laboratories Market Share by Region, 2022-2032 (%)
7.4 Hospitals & Clinics
7.4.1 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ Mn)
7.4.2 Hospitals & Clinics Market Share by Region, 2022-2032 (%)

8 Global Molecular Diagnostics Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
8.3 COVID-19 Impact Analysis

9 North America Molecular Diagnostics Market Analysis
9.1 Key Findings
9.2 North America Molecular Diagnostics Market Attractiveness Index
9.3 North America Molecular Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Mn)
9.4 North America Molecular Diagnostics Market Size Estimation and Forecast by Country
9.5 North America Molecular Diagnostics Market Size Estimation and Forecast by Type
9.6 North America Molecular Diagnostics Market Size Estimation and Forecast by Application
9.7 North America Molecular Diagnostics Market Size Estimation and Forecast by End-users
9.8 U.S.
9.9 Canada

10 Europe Molecular Diagnostics Market Analysis
10.1 Key Findings
10.2 Europe Molecular Diagnostics Market Attractiveness Index
10.3 Europe Molecular Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Mn)
10.4 Europe Molecular Diagnostics Market Size Estimation and Forecast by Country
10.5 Europe Molecular Diagnostics Market Size Estimation and Forecast by Type
10.6 Europe Molecular Diagnostics Market Size Estimation and Forecast by Application
10.7 Europe Molecular Diagnostics Market Size Estimation and Forecast by End-users
10.8 Germany
10.9 France
10.10 UK
10.11 Italy
10.12 Spain
10.13 Russia

11 Asia Pacific Molecular Diagnostics Market Analysis
11.1 Key Findings
11.2 Asia Pacific Molecular Diagnostics Market Attractiveness Index
11.3 Asia Pacific Molecular Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Mn)
11.4 Asia Pacific Molecular Diagnostics Market Size Estimation and Forecast by Country
11.5 Asia Pacific Molecular Diagnostics Market Size Estimation and Forecast by Type
11.6 Asia Pacific Molecular Diagnostics Market Size Estimation and Forecast by Application
11.7 Asia Pacific Molecular Diagnostics Market Size Estimation and Forecast by End-users
11.8 Japan
11.9 China
11.10 India
11.11 Australia
11.12 South Korea
11.13 Rest of Asia Pacific

12 Latin America Molecular Diagnostics Market Analysis
12.1 Key Findings
12.2 Latin America Molecular Diagnostics Market Attractiveness Index
12.3 Latin America Molecular Diagnostics Market by Country, 2022, 2027 & 2032 (US$ million)
12.4 Latin America Molecular Diagnostics Market Size Estimation and Forecast by Country
12.5 Latin America Molecular Diagnostics Market Size Estimation and Forecast by Type
12.6 Latin America Molecular Diagnostics Market Size Estimation and Forecast by Application
12.7 Latin America Molecular Diagnostics Market Size Estimation and Forecast by End-users
12.8 Brazil
12.9 Mexico

13 Middle East & Africa Molecular Diagnostics Market Analysis
13.1 Key Findings
13.2 Middle East & Africa Molecular Diagnostics Market Attractiveness Index
13.3 Middle East & Africa Molecular Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Mn)
13.4 Middle East & Africa Molecular Diagnostics Market Size Estimation and Forecast by Country
13.5 Middle East & Africa Molecular Diagnostics Market Size Estimation and Forecast by Type
13.6 Middle East & Africa Molecular Diagnostics Market Size Estimation and Forecast by Application
13.7 Middle East & Africa Molecular Diagnostics Market Size Estimation and Forecast by End-users
13.8 GCC
13.9 South Africa

14 Competitive Landscape
14.1 Company Share Analysis
14.2 Key Business Strategy Analysis

15 Company Profiles
15.1 Abbott Laboratories Inc.
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Financial Analysis
15.1.4 Product Benchmarking
15.1.5 Strategic Outlook
15.2 F. Hoffmann-La Roche Ltd.
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.4 Product Benchmarking
15.2.5 Strategic Outlook
15.3 Hologic Inc.
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Qiagen N.V.
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 Becton, Dickinson and Company
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 Cepheid
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Product Benchmarking
15.6.4 Strategic Outlook
15.7 Siemens Medical Solutions Inc.
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Danaher Corp.
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Agilent Technologies Inc.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 Exact Sciences Corp.
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 Abacus Diagnostica Oy [Uniogen]
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Product Benchmarking
Rapid GenomEra PCR tests
15.11.4 Strategic Outlook
15.12 PerkinElmer, Inc.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.4 Product Benchmarking
15.12.5 Strategic Outlook
15.13 bioMérieux SA
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.4 Product Benchmarking
15.13.5 Strategic Outlook
15.14 Thermo Fisher Scientific
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Financial Analysis
15.14.4 Product Benchmarking
15.14.5 Strategic Outlook

16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players

List of Tables
Table 1 Global Molecular Diagnostics Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 3 Diagnostic Kit Manufacturers Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 4 OEM Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 5 Software Providers Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 6 Infectious Disease Testing Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 7 Covid-19 Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 8 Hepatitis Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 9 HIV Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 10 CT/NG Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 11 HAI Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 12 HPV Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 13 Tuberculosis Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 14 Influenza Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 15 Others Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 16 Oncology Testing Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 17 Genetic Testing Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 18 Others Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 19 Global Molecular Diagnostics Market Forecast by Therapeutics, 2022-2032 (US$ million, AGR %, CAGR %)
Table 20 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 21 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 22 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 23 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 24 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 25 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 26 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 27 North America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 28 North America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 29 North America Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 30 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 31 North America Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 32 U.S. Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 33 Canada Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 34 Europe Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 35 Europe Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 36 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 37 Europe Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 38 Germany Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 39 France Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 40 UK Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 41 Italy Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 42 Spain Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 43 Russia Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 44 Asia Pacific Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 45 Asia Pacific Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 46 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 47 Asia Pacific Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 48 Japan Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 49 China Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 50 India Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 51 Australia Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 52 South Korea Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 53 Rest of Asia Pacific Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 54 Latin America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 55 Latin America Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 56 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 57 Latin America Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 58 Brazil Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 59 Mexico Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 60 Middle East & Africa Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 61 Middle East & Africa Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 62 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 63 Middle East & Africa Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 64 GCC Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 65 South Africa Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 66 Key Business Strategies Adopted by Key Players in Global Molecular Diagnostics Market
Table 67 Abbott Laboratories Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 68 Abbott: Product Benchmarking
Table 69 Abbott Laboratories Inc.: Strategic Outlook
Table 70 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 71 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 72 F. Hoffmann-La Roche Ltd.: Strategic Outlook
Table 73 Hologic Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Hologic Inc.: Product Benchmarking
Table 75 Hologic Inc.: Strategic Outlook
Table 76 Qiagen N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Qiagen N.V.: Product Benchmarking
Table 78 Qiagen N.V.: Strategic Outlook
Table 79 Becton, Dickinson and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Becton, Dickinson and Company: Product Benchmarking
Table 81 Becton, Dickinson and Company: Strategic Outlook
Table 82 Cepheid: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Cepheid: Product Benchmarking
Table 84 Cepheid: Strategic Outlook
Table 85 Siemens Medical Solutions Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Siemens Medical Solutions Inc.: Product Benchmarking
Table 87 Siemens Medical Solutions Inc.: Strategic Outlook
Table 88 Danaher Corp.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Danaher Corp.: Product Benchmarking
Table 90 Danaher Corp.: Strategic Outlook
Table 91 Agilent Technologies Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Agilent Technologies Inc.: Product Benchmarking
Table 93 Agilent Technologies Inc.: Strategic Outlook
Table 94 Exact Sciences Corp.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Exact Sciences Corp.: Product Benchmarking
Table 96 Exact Sciences Corp.: Strategic Outlook
Table 97 Abacus Diagnostica Oy: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Abacus Diagnostica Oy: Product Benchmarking
Table 99 Abacus Diagnostica Oy: Strategic Outlook
Table 100 PerkinElmer, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 PerkinElmer, Inc.: Product Benchmarking
Table 102 PerkinElmer, Inc.: Strategic Outlook
Table 103 bioMérieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 bioMérieux SA: Product Benchmarking
Table 105 bioMérieux SA: Strategic Outlook
Table 106 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Thermo Fisher Scientific: Product Benchmarking
Table 108 Thermo Fisher Scientific: Strategic Outlook
 
List of Figures
Figure 1 Global Molecular Diagnostics Market Segmentation
Figure 2 Global Molecular Diagnostics Market Forecast by Type: Market Attractiveness Index
Figure 3 Global Molecular Diagnostics Market by Therapeutics: Market Attractiveness Index
Figure 4 Global Molecular Diagnostics Market by Technology: Market Attractiveness Index
Figure 5 Global Molecular Diagnostics Market by End-users: Market Attractiveness Index
Figure 6 Global Molecular Diagnostics Market: Market Dynamics
Figure 7 Global Molecular Diagnostics Market: Porter’s Five Forces Analysis
Figure 8 Global Molecular Diagnostics Market: PESTEL Analysis
Figure 9 Global Molecular Diagnostics Market Forecast by Type 2022, 2027, 2032 (Revenue, CAGR%)
Figure 10 Global Molecular Diagnostics Market Share Forecast by Type, 2022, 2032 (%)
Figure 11 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million)
Figure 12 Testing Service Provider Market Share Forecast by Region, 2022-2032 (%)
Figure 13 Diagnostic Kit Manufacturer Market Forecast by Region, 2022-2032 (US$ million)
Figure 14 Diagnostic Kit Manufacturers Market Share Forecast by Region, 2022-2032 (%)
Figure 15 OEM Market Forecast by Region, 2022-2032 (US$ million)
Figure 16 OEM Market Share Forecast by Region, 2022-2032 (%)
Figure 17 Software Providers Market Forecast by Region, 2022-2032 (US$ million)
Figure 18 Software Providers Market Share Forecast by Region, 2022-2032 (%)
Figure 19 Global Molecular Diagnostics Market Forecast by Application 2022, 2027, 2032 (Revenue, CAGR%)
Figure 20 Global Molecular Diagnostics Market Share Forecast by Application, 2022, 2032 (%)
Figure 21 Infectious Disease Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 22 Infectious Disease Testing Market Share Forecast by Region, 2022-2032 (%)
Figure 23 Covid-19 Market Forecast by Region, 2022-2032 (US$ million)
Figure 24 Covid-19 Market Share Forecast by Region, 2022-2032 (%)
Figure 25 Hepatitis Market Forecast by Region, 2022-2032 (US$ million)
Figure 26 Hepatitis Market Share Forecast by Region, 2022-2032 (%)
Figure 27 HIV Market Forecast by Region, 2022-2032 (US$ million)
Figure 28 HIV Market Share Forecast by Region, 2022-2032 (%)
Figure 29 CT/NG Market Forecast by Region, 2022-2032 (US$ million)
Figure 30 CT/NG Market Share Forecast by Region, 2022-2032 (%)
Figure 31 HAI Market Forecast by Region, 2022-2032 (US$ million)
Figure 32 HAI Market Share Forecast by Region, 2022-2032 (%)
Figure 33 HPV Market Forecast by Region, 2022-2032 (US$ million)
Figure 34 HPV Market Share Forecast by Region, 2022-2032 (%)
Figure 35 Tuberculosis Market Forecast by Region, 2022-2032 (US$ million)
Figure 36 Tuberculosis Market Share Forecast by Region, 2022-2032 (%)
Figure 37 Influenza Market Forecast by Region, 2022-2032 (US$ million)
Figure 38 Influenza Market Share Forecast by Region, 2022-2032 (%)
Figure 39 Others Market Forecast by Region, 2022-2032 (US$ million)
Figure 40 Others Market Share Forecast by Region, 2022-2032 (%)
Figure 41 Oncology Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 42 Oncology Testing Market Share Forecast by Region, 2022-2032 (%)
Figure 43 Genetic Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 44 Genetic Testing Market Share Forecast by Region, 2022-2032 (%)
Figure 45 Others Market Forecast by Region, 2022-2032 (US$ million)
Figure 46 Others Market Share Forecast by Region, 2022-2032 (%)
Figure 47 Global Molecular Diagnostics Market Forecast by End User 2022- 2032 (Revenue, CAGR%)
Figure 48 Global Molecular Diagnostics Market Forecast by End User 2022-2032 (US$ million, AGR %)
Figure 49 Global Molecular Diagnostics Market Share Forecast by Type, 2022, 2027, 2032 (%)
Figure 50 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ million)
Figure 51 Diagnostic Laboratories Market Share Forecast by Region, 2022-2032 (%)
Figure 52 Hospitals and Laboratories Market Forecast by Region, 2022-2032 (US$ million)
Figure 53 Hospitals & Clinics Market Share Forecast by Region, 2022-2032 (%)
Figure 54 Global Molecular Diagnostics Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR%)
Figure 55 Global Molecular Diagnostics Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 56 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 57 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 58 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 59 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 60 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 61 North America Molecular Diagnostics Market Attractiveness Index
Figure 62 North America Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 63 North America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 64 North America Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 65 North America Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 66 North America Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 67 North America Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 68 North America Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 69 North America Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 70 North America Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 71 U.S. Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 72 Canada Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 73 Europe Molecular Diagnostics Market Attractiveness Index
Figure 74 Europe Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 75 Europe Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 76 Europe Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 77 Europe Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 78 Europe Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 79 Europe Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 80 Europe Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 81 Europe Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 82 Europe Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 83 Germany Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 84 France Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 85 UK Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 86 Italy Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 87 Spain Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 88 Russia Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 89 Asia Pacific Molecular Diagnostics Market Attractiveness Index
Figure 90 Asia Pacific Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 91 Asia Pacific Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 92 Asia Pacific Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 93 Asia Pacific Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 94 Asia Pacific Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 95 Asia Pacific Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 96 Asia Pacific Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 97 Asia Pacific Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 98 Asia Pacific Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 99 Japan Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 100 China Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 101 India Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 102 Australia Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 103 South Korea Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 104 Rest of Asia Pacific Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 105 Latin America Molecular Diagnostics Market Attractiveness Index
Figure 106 Latin America Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 107 Latin America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 108 Latin America Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 109 Latin America Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 110 Latin America Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 111 Latin America Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 112 Latin America Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 113 Latin America Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 114 Latin America Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 115 Brazil Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 116 Mexico Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 117 Middle East & Africa Molecular Diagnostics Market Attractiveness Index
Figure 118 Middle East & Africa Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 119 Middle East & Africa Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 120 Middle East & Africa Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 121 Middle East & Africa Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 122 Middle East & Africa Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 123 Middle East & Africa Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 124 Middle East & Africa Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 125 Middle East & Africa Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 126 Middle East & Africa Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 127 GCC Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 128 South Africa Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 129 Global Molecular Diagnostics Market: Company Share Analysis, 2021
Figure 130 Abbott Laboratories Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 131 Abbott Laboratories Inc.: Regional Market Shares, 2021
Figure 132 Abbott Laboratories Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 133 Abbott Laboratories Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 134 F. Hoffmann-La Roche Ltd.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 135 F. Hoffmann-La Roche Ltd.: Regional Market Shares, 2021
Figure 136 F. Hoffmann-La Roche Ltd.: Operating Profit, 2016-2021 (US$ million, AGR%)
Figure 137 F. Hoffmann-La Roche Ltd.: R&D, 2016-2021 (US$ million, AGR%)
Figure 138 Hologic Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 139 Hologic Inc.: Regional Market Shares, 2021
Figure 140 Hologic Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 141 Hologic Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 142 Qiagen N.V.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 143 Qiagen N.V.: Regional Market Shares, 2021
Figure 144 Qiagen N.V.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 145 Qiagen N.V.: R&D, 2016-2021 (US$ million, AGR%)
Figure 146 Becton, Dickinson and Company: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 147 Becton, Dickinson and Company: Regional Market Shares, 2021
Figure 148 Becton, Dickinson and Company: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 149 Becton, Dickinson and Company: R&D, 2016-2019 (US$ million, AGR%)
Figure 150 Siemens Medical Solutions Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 151 Siemens Medical Solutions Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 152 Siemens Medical Solutions Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 153 Danaher Corp.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 154 Danaher Corp.: Regional Market Shares, 2021
Figure 155 Danaher Corp.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 156 Agilent Technologies Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 157 Agilent Technologies Inc.: Regional Market Shares, 2021
Figure 158 Agilent Technologies Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 159 Agilent Technologies Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 160 Exact Sciences Corp.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 161 Exact Sciences Corp.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 162 Exact Sciences Corp.: R&D, 2016-2021 (US$ million, AGR%)
Figure 163 PerkinElmer, Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 164 PerkinElmer, Inc.: Regional Market Shares, 2020
Figure 165 PerkinElmer, Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 166 PerkinElmer, Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 167 bioMérieux SA: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 168 bioMérieux SA: Regional Market Shares, 2019
Figure 169 bioMérieux SA: Gross Profit, 2016-2019 (US$ million, AGR%)
Figure 170 bioMérieux SA: R&D, 2016-2019 (US$ million, AGR%)
Figure 171 Thermo Fisher Scientific: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 172 Thermo Fisher Scientific: Regional Market Shares, 2021
Figure 173 Thermo Fisher Scientific: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 174 Thermo Fisher Scientific: R&D, 2016-2021 (US$ million, AGR%)